These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8437650)

  • 21. Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS.
    Khullar A; Chue P; Tibbo P
    J Psychiatry Neurosci; 2001 Jan; 26(1):55-9. PubMed ID: 11212595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tranylcypromine treatment of major depression.
    Liebowitz MR
    J Clin Psychiatry; 1987 Jul; 48(7):303. PubMed ID: 3597337
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid conversion from one monoamine oxidase inhibitor to another.
    Szuba MP; Hornig-Rohan M; Amsterdam JD
    J Clin Psychiatry; 1997 Jul; 58(7):307-10. PubMed ID: 9269251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug treatment of obsessive-compulsive disorder. With proper drugs and some patience many patients can be helped].
    Mavrogiorgou P; Hegerl U
    MMW Fortschr Med; 1999 Sep; 141(39):32-4, 37. PubMed ID: 10897982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
    Schmauss M
    Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L; Topuz A
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).
    Jenike MA
    Am J Psychiatry; 1985 Jun; 142(6):763-4. PubMed ID: 4003602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paternal overprotection in obsessive-compulsive disorder and depression with obsessive traits.
    Yoshida T; Taga C; Matsumoto Y; Fukui K
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):533-8. PubMed ID: 16194254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C; Millet B; Olie JP
    Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient compliance with MAO inhibitor therapy.
    Walker JI; Davidson J; Zung WW
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):78-80. PubMed ID: 6735998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bupropion-tranylcypromine combination for treatment-refractory depression.
    Pierre JM; Gitlin MJ
    J Clin Psychiatry; 2000 Jun; 61(6):450-1. PubMed ID: 10901349
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of 100 patients treated with iproniazid or "the myth of MAO inhibitors"].
    Planche R; Planche F; Planche-Fourthin I; Charbonnier JF; Chassaing JL
    Ann Med Psychol (Paris); 1992; 150(2-3):220-3; discussion 223-4. PubMed ID: 1343523
    [No Abstract]   [Full Text] [Related]  

  • 35. MAO inhibitor therapy in trichotillomania associated with depression: case report.
    Krishnan RR; Davidson J; Miller R
    J Clin Psychiatry; 1984 Jun; 45(6):267-8. PubMed ID: 6725219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obsessive-compulsive disorder with unusual themes.
    Gangdev PS
    S Afr Med J; 1996 Jun; 86(6 Suppl):748, 750. PubMed ID: 9180770
    [No Abstract]   [Full Text] [Related]  

  • 37. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ
    J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant treatment with MAO-inhibitors during general and regional anesthesia: a review and case report of spinal anesthesia for lower extremity surgery without discontinuation of tranylcypromine.
    Krings-Ernst I; Ulrich S; Adli M
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):763-70. PubMed ID: 23993253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with low doses of tranylcypromine resulted in a disappointing remission rate.
    Nolen WA; van den Broek WW; Birkenhäger TK
    Am J Psychiatry; 2007 Mar; 164(3):524; author reply 524. PubMed ID: 17329480
    [No Abstract]   [Full Text] [Related]  

  • 40. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
    Fallon B; Foote B; Walsh BT; Roose SP
    J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.